ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,045, issued on July 7, was assigned to PREMARK PHARMA GMBH (Reinach, Switzerland). "Treatment of ocular disease" was invented by Ian Vessey ... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,046, issued on July 7, was assigned to MERCK PATENT GMBH (Darmstadt, Germany) and RYVU THERAPEUTICS S.A. (Krawkow, Poland). "Substituted tet... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,047, issued on July 7, was assigned to THE GEORGE INSTITUTE FOR GLOBAL HEALTH (Randwick, Australia). "Compositions for the treatment of hype... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,048, issued on July 7, was assigned to MINORYX THERAPEUTICS S.L. (Mataro Barcelona, Spain). "Method of administering a therapeutically effec... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,049, issued on July 7, was assigned to SHANGHAI WD PHARMACEUTICAL Co. LTD (Shanghai). "Pharmaceutical composition containing dabigatran etex... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,050, issued on July 7, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain). "Compositions and their use for the t... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,051, issued on July 7, was assigned to SHENZHEN FIRST UNION TECHNOLOGY Co. LTD. (Shenzhen City, China) and SHENZHEN HERUI BIOTECHNOLOGY Co. L... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,052, issued on July 7, was assigned to Exelixis Inc. (Alameda, Calif.). "Combinations for the treatment of cancer" was invented by Gisela Sc... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,053, issued on July 7, was assigned to 60 Degrees Pharmaceuticals Inc. (Washington). "Methods for the treatment and prevention of lung infec... Read More
ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,054, issued on July 7, was assigned to Lupin Ltd. (Maharastra Mumbai, India). "Substituted nucleoside analogs as PRMT5 inhibitors" was inven... Read More